Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 8/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 7/20 | 0.32 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 3/20 | 0.31 |
| ▸ | RAB9A | P51151 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.30 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7095595 | 1.00 | NPBWR1 (0.32) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7094438 | 0.89 | NPBWR1 (0.35) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7094437 | 0.89 | NPBWR1 (0.35) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7093687 | 0.89 | ALDH1A1 (0.38) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7018209 | 0.89 | ALDH1A1 (0.38) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7092597 | 0.88 | NPBWR1 (0.32) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7092596 | 0.88 | NPBWR1 (0.32) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7092361 | 0.87 | AGPAT2 (0.33) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7092357 | 0.87 | AGPAT2 (0.33) | NPBWR1MCHR1CCR1NPC1RAB9A | |
| SCHEMBL7018601 | 0.86 | NPC1 (0.34) | NPBWR1MCHR1CCR1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030130123-A1 | 2-Phenyl-2h-pyridazine-3-ones | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130123-A1 | 2-Phenyl-2h-pyridazine-3-ones | CNPY2, CBR3, CBR1 | NPBWR1 371/4885MCHR1 1187/4885CCR1 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.